Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

22.42
+0.22501.01%
Volume:229.58K
Turnover:5.14M
Market Cap:729.73M
PE:17.65
High:22.64
Open:22.36
Low:22.14
Close:22.19
52wk High:50.79
52wk Low:21.65
Shares:32.56M
Float Shares:31.37M
Volume Ratio:0.55
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.73
ROE:17.61%
ROA:5.75%
PB:2.34
PE(LYR):12.96

Loading ...

May 12, 2026

Major Issues Report

Form 8-K - Current report
May 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 07, 2026

Major Issues Report

Form 8-K - Current report
Mar 19, 2026

Major Issues Report

Form 8-K - Current report
Mar 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Dec 30, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report